Your browser doesn't support javascript.
loading
DDX3X induces primary EGFR-TKI resistance based on intratumor heterogeneity in lung cancer cells harboring EGFR-activating mutations.
Nozaki, Koichiro; Kagamu, Hiroshi; Shoji, Satoshi; Igarashi, Natsue; Ohtsubo, Aya; Okajima, Masaaki; Miura, Satoru; Watanabe, Satoshi; Yoshizawa, Hirohisa; Narita, Ichiei.
Afiliação
  • Nozaki K; Division of Respiratory Medicine, Department of Homeostatic Regulation and Development, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
  • Kagamu H; Division of Respiratory Medicine, Department of Homeostatic Regulation and Development, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
  • Shoji S; Division of Respiratory Medicine, Department of Homeostatic Regulation and Development, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
  • Igarashi N; Division of Respiratory Medicine, Department of Homeostatic Regulation and Development, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
  • Ohtsubo A; Division of Respiratory Medicine, Department of Homeostatic Regulation and Development, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
  • Okajima M; Division of Respiratory Medicine, Department of Homeostatic Regulation and Development, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
  • Miura S; Division of Respiratory Medicine, Department of Homeostatic Regulation and Development, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
  • Watanabe S; Bioscience Medical Research Center, Niigata University Medical and Dental Hospital, Niigata, Japan.
  • Yoshizawa H; Bioscience Medical Research Center, Niigata University Medical and Dental Hospital, Niigata, Japan.
  • Narita I; Division of Respiratory Medicine, Department of Homeostatic Regulation and Development, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
PLoS One ; 9(10): e111019, 2014.
Article em En | MEDLINE | ID: mdl-25343452
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Heterogeneidade Genética / Resistencia a Medicamentos Antineoplásicos / Inibidores de Proteínas Quinases / RNA Helicases DEAD-box / Receptores ErbB / Neoplasias Pulmonares / Mutação Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Heterogeneidade Genética / Resistencia a Medicamentos Antineoplásicos / Inibidores de Proteínas Quinases / RNA Helicases DEAD-box / Receptores ErbB / Neoplasias Pulmonares / Mutação Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Japão